Adjuvant chemotherapy for bladder cancer.

about

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

P2860

Q37489176-48A824A3-B41F-427B-A2E0-B9AB04F3ACFC

P2860

Adjuvant chemotherapy for bladder cancer.

Item

http://www.wikidata.org/entity/Q36334879

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Adjuvant chemotherapy for bladder cancer.

@ast

Adjuvant chemotherapy for bladder cancer.

@en

type

Item

label

Adjuvant chemotherapy for bladder cancer.

@ast

Adjuvant chemotherapy for bladder cancer.

@en

prefLabel

Adjuvant chemotherapy for bladder cancer.

@ast

Adjuvant chemotherapy for bladder cancer.

@en

P1476

Adjuvant chemotherapy for bladder cancer.

@en

P2093

Cora N Sternberg

http://www.w3.org/2001/XMLSchema#string

Fabio Calabró

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.

Current perspectives in muscle invasive bladder cancer.

Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?

New drugs and new approaches in metastatic bladder cancer.

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.

Accumulation of nuclear p53 and tumor progression in bladder cancer.

Bladder cancer "adjuvant-lite": tastes great (works as well) and less filling (less toxic)?

Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).

P304

987-992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.5.6.987

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16336089

http://www.w3.org/2001/XMLSchema#string

Adjuvant chemotherapy for bladder cancer.

about

P2860

P2860

Adjuvant chemotherapy for bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698